April 6, 2018 / 11:08 AM / 7 months ago

BRIEF-Cipher Pharmaceuticals Acquires Canadian Rights To U.S. FDA-Approved A 101 40% Topical Solution

1 分钟阅读

April 6 (Reuters) - Cipher Pharmaceuticals:

* CIPHER PHARMACEUTICALS ACQUIRES EXCLUSIVE CANADIAN RIGHTS TO U.S. FDA-APPROVED A-101 40% TOPICAL SOLUTION FROM ACLARIS THERAPEUTICS

* CIPHER PHARMACEUTICALS INC - ACLARIS WILL RECEIVE AN UPFRONT PAYMENT OF US$1.0 MLN Source text for Eikon: Further company coverage:

0 : 0